Cargando…
Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model
The host defense peptide caerin 1.9 was originally isolated from skin secretions of an Australian tree frog and inhibits the growth of a wide range of bacteria in vitro. In this study, we demonstrated that caerin 1.9 shows high bioactivity against several bacteria strains, such as Staphylococcus aur...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552723/ https://www.ncbi.nlm.nih.gov/pubmed/34259550 http://dx.doi.org/10.1128/spectrum.00051-21 |
_version_ | 1784591439669231616 |
---|---|
author | Chen, Shu Zhang, Pingping Xiao, Liyin Liu, Ying Wu, Kuihai Ni, Guoying Li, Hejie Wang, Tianfang Wu, Xiaolian Chen, Guoqiang Liu, Xiaosong |
author_facet | Chen, Shu Zhang, Pingping Xiao, Liyin Liu, Ying Wu, Kuihai Ni, Guoying Li, Hejie Wang, Tianfang Wu, Xiaolian Chen, Guoqiang Liu, Xiaosong |
author_sort | Chen, Shu |
collection | PubMed |
description | The host defense peptide caerin 1.9 was originally isolated from skin secretions of an Australian tree frog and inhibits the growth of a wide range of bacteria in vitro. In this study, we demonstrated that caerin 1.9 shows high bioactivity against several bacteria strains, such as Staphylococcus aureus, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus (MRSA), and Streptococcus haemolyticus in vitro. Importantly, unlike the antibiotic Tazocin, caerin 1.9 does not induce bacterial resistance after 30 rounds of in vitro culture. Moreover, caerin 1.1, another peptide of the caerin family, has an additive antibacterial effect when used together with caerin 1.9. Furthermore, caerin 1.1 and 1.9 prepared in the form of a temperature-sensitive gel inhibit MRSA growth in a skin bacterial infection model of two murine strains. These results indicate that caerin 1.1 and 1.9 peptides could be considered an alternative for conventional antibiotics. IMPORTANCE Antibiotic-resistant bacteria cause severe problems in the clinic. We show in our paper that two short peptides isolated from an Australian frog and prepared in the form of a gel are able to inhibit the growth of antibiotic-resistant bacteria in mice, and, unlike antibiotics, these peptides do not lead to the development of peptide-resistant bacteria strains. |
format | Online Article Text |
id | pubmed-8552723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-85527232021-11-08 Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model Chen, Shu Zhang, Pingping Xiao, Liyin Liu, Ying Wu, Kuihai Ni, Guoying Li, Hejie Wang, Tianfang Wu, Xiaolian Chen, Guoqiang Liu, Xiaosong Microbiol Spectr Research Article The host defense peptide caerin 1.9 was originally isolated from skin secretions of an Australian tree frog and inhibits the growth of a wide range of bacteria in vitro. In this study, we demonstrated that caerin 1.9 shows high bioactivity against several bacteria strains, such as Staphylococcus aureus, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus (MRSA), and Streptococcus haemolyticus in vitro. Importantly, unlike the antibiotic Tazocin, caerin 1.9 does not induce bacterial resistance after 30 rounds of in vitro culture. Moreover, caerin 1.1, another peptide of the caerin family, has an additive antibacterial effect when used together with caerin 1.9. Furthermore, caerin 1.1 and 1.9 prepared in the form of a temperature-sensitive gel inhibit MRSA growth in a skin bacterial infection model of two murine strains. These results indicate that caerin 1.1 and 1.9 peptides could be considered an alternative for conventional antibiotics. IMPORTANCE Antibiotic-resistant bacteria cause severe problems in the clinic. We show in our paper that two short peptides isolated from an Australian frog and prepared in the form of a gel are able to inhibit the growth of antibiotic-resistant bacteria in mice, and, unlike antibiotics, these peptides do not lead to the development of peptide-resistant bacteria strains. American Society for Microbiology 2021-07-14 /pmc/articles/PMC8552723/ /pubmed/34259550 http://dx.doi.org/10.1128/spectrum.00051-21 Text en Copyright © 2021 Chen et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Chen, Shu Zhang, Pingping Xiao, Liyin Liu, Ying Wu, Kuihai Ni, Guoying Li, Hejie Wang, Tianfang Wu, Xiaolian Chen, Guoqiang Liu, Xiaosong Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model |
title | Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model |
title_full | Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model |
title_fullStr | Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model |
title_full_unstemmed | Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model |
title_short | Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model |
title_sort | caerin 1.1 and 1.9 peptides from australian tree frog inhibit antibiotic-resistant bacteria growth in a murine skin infection model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552723/ https://www.ncbi.nlm.nih.gov/pubmed/34259550 http://dx.doi.org/10.1128/spectrum.00051-21 |
work_keys_str_mv | AT chenshu caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT zhangpingping caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT xiaoliyin caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT liuying caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT wukuihai caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT niguoying caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT lihejie caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT wangtianfang caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT wuxiaolian caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT chenguoqiang caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel AT liuxiaosong caerin11and19peptidesfromaustraliantreefroginhibitantibioticresistantbacteriagrowthinamurineskininfectionmodel |